Pulse Biosciences (PLSE) Total Non-Current Liabilities (2016 - 2025)

Pulse Biosciences has reported Total Non-Current Liabilities for 10 years, with the latest figure at $13.9 million in Q4 2025.

• For the quarter ending Q4 2025, Total Non-Current Liabilities fell 21.11% year-over-year to $13.9 million; the trailing twelve-month figure through Dec 2025 stood at $13.9 million (down 21.11% YoY), and the FY2025 full-year result was $13.9 million, down 21.11% from the prior year.
• Total Non-Current Liabilities for Q4 2025 stood at $13.9 million, down from $16.1 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $81.4 million in Q3 2022, with the low at $13.8 million in Q3 2023.
• Average Total Non-Current Liabilities over 5 years is $30.3 million, with a median of $17.2 million recorded in 2022.
• Year-over-year, Total Non-Current Liabilities jumped 497.24% in 2021 and plunged 83.04% in 2023.
• Tracing PLSE's Total Non-Current Liabilities over 5 years: stood at $14.8 million in 2021, then surged by 441.6% to $80.1 million in 2022, then sank by 81.54% to $14.8 million in 2023, then advanced by 18.95% to $17.6 million in 2024, then decreased by 21.11% to $13.9 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $13.9 million (Q4 2025), $16.1 million (Q3 2025), and $15.8 million (Q2 2025), per Business Quant data.

Peer Comparison